Private Placement

Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced on Tuesday that it has entered into subscription agreements with certain institutional investors in a private placement offering of 6,993,007 units at $4.29 per unit for aggregate gross proceeds of approximately $30 million. Details Each...

Latin American licensed producer of medicinal cannabis and cannabis-derived products Blueberries Medical Corp. (CSE:BBM) (OTC:BBRRF) (FRA: 1OA) wrapped up 2023 with an announcement of a non-brokered private placement consisting of the sale of 180,716,00 common shares at CA$0.011 ($0.0083) per...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has closed the second and final tranche of its previously announced private placement offering of its units. Under the offering, Innocan issued 4,005,408 units at $0.30 per unit for aggregate gross proceeds of $1,201,622. The company...

Cannabis cultivation and retail company Glass House Brands Inc. (NEO: GLAS.A.U) (NEO: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) has completed the first tranche of its $15 million Series D preferred stock offering. What Happened The Long Beach, California-base company said on Thursday that it had...

Psychedelics biotech giant COMPASS Pathways (NASDAQ: CMPS) has entered into a securities purchase agreement for an initial $125 million and potential additional of $160 million, with a select group of healthcare specialist investors.  Led by TCGX and Aisling Capital and the...

TerrAscend Corp. (OTCQX: TRSSF) (NASDAQ: TER) announced on June 23 that it closed the first tranche of its previously announced concurrent private placements for total gross proceeds of approximately $16 million, upsizing the offering to $20 million. A second tranche closing is scheduled for...

Drug development can be notoriously slow, and it can take some companies 10 years or more to pass through all the trials and tests required by the Food and Drug Administration (FDA). However, when a company is bringing a drug to trial in near-record time, it’s understandable that company...

Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) raised funds to treat infectious diseases and rare disorders, including meth addiction. The company closed a private placement deal — with the original offer extended to Quebec-based investors — issuing more than 28.6...

Life sciences biotech Psyence Group Inc. (OTCQB: PSYGF) has closed the second tranche of its previously announced private placement of up to $2.2 million (CA$3 million). The company issued more than 7.7 million common shares at a unit price of $0.09 (CA$0.12) for gross proceeds of $680.458 (CA$930,...

A tech company responsible for creating a clinical testing platform that uses AI and machine learning for the detection of earliest cognitive impairment signs, Cognetivity Neurosciences Ltd. (OTCQB: CGNSF), has completed its non-brokered private placement raising a total $3.323.279. The...

Trees Corporation (NEO: TREE) has closed a non-brokered private placement of its 34.17 million at $0.03 per unit for gross proceeds of approximately $1.03 million. Under the private placement, each unit is comprised of one common share and one-half of one common share purchase warrant of the...

Simply Better Brands Corp. (TSX: SBBC) (OTCQB: PKANF) announced that it intends to increase the size of the non-brokered private placement to up to 580,046 units of the company at a price of CA$4.31 ($3.4) per unit for aggregate gross proceeds of up to roughly CA$2.5 million. The net proceeds of...

Cansortium Inc. (CSE:TIUM.U) (OTCQB: CNTMF) has secured some $12 million in financing through a sale of roughly 17.14 million of its units at 70 cents per unit. The Miami company expects to close the private placement over the next few days. The financing will boost its operations in Florida, which...

Cannabis company Harborside Inc. (CSE: HBOR) (OTCQX: HBORF) recently raised some CA$35.1 million (US$27.8 million) through a brokered private placement. The Oakland, California-based company closed its previously announced upsized brokered private placement of its units at CA$2.55 per SVS Unit,...

Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) is poised to raise some CA$25.2 million ($19.8 million) in funding via a bought deal private placement deal. Under the agreement, the New York cannabis company agreed to sell some 2.8 million of its common shares to Canaccord Genuity Corp. at CA$9 ($7.1...